422 related articles for article (PubMed ID: 32231665)
1. Pulmonary Pathogens Adapt to Immune Signaling Metabolites in the Airway.
Riquelme SA; Wong Fok Lung T; Prince A
Front Immunol; 2020; 11():385. PubMed ID: 32231665
[TBL] [Abstract][Full Text] [Related]
2. Immunometabolites Drive Bacterial Adaptation to the Airway.
Tomlinson KL; Prince AS; Wong Fok Lung T
Front Immunol; 2021; 12():790574. PubMed ID: 34899759
[No Abstract] [Full Text] [Related]
3. Association of Diverse Staphylococcus aureus Populations with Pseudomonas aeruginosa Coinfection and Inflammation in Cystic Fibrosis Airway Infection.
Wieneke MK; Dach F; Neumann C; Görlich D; Kaese L; Thißen T; Dübbers A; Kessler C; Große-Onnebrink J; Küster P; Schültingkemper H; Schwartbeck B; Roth J; Nofer JR; Treffon J; Posdorfer J; Boecken JM; Strake M; Abdo M; Westhues S; Kahl BC
mSphere; 2021 Jun; 6(3):e0035821. PubMed ID: 34160233
[TBL] [Abstract][Full Text] [Related]
4. The Small RNA ErsA Plays a Role in the Regulatory Network of Pseudomonas aeruginosa Pathogenicity in Airway Infections.
Ferrara S; Rossi A; Ranucci S; De Fino I; Bragonzi A; Cigana C; Bertoni G
mSphere; 2020 Oct; 5(5):. PubMed ID: 33055260
[TBL] [Abstract][Full Text] [Related]
5. Adaptation of Pseudomonas aeruginosa in Cystic Fibrosis airways influences virulence of Staphylococcus aureus in vitro and murine models of co-infection.
Baldan R; Cigana C; Testa F; Bianconi I; De Simone M; Pellin D; Di Serio C; Bragonzi A; Cirillo DM
PLoS One; 2014; 9(3):e89614. PubMed ID: 24603807
[TBL] [Abstract][Full Text] [Related]
6. Airway immunometabolites fuel Pseudomonas aeruginosa infection.
Riquelme SA; Prince A
Respir Res; 2020 Dec; 21(1):326. PubMed ID: 33302964
[TBL] [Abstract][Full Text] [Related]
7. Pseudomonas aeruginosa and Klebsiella pneumoniae Adaptation to Innate Immune Clearance Mechanisms in the Lung.
Riquelme SA; Ahn D; Prince A
J Innate Immun; 2018; 10(5-6):442-454. PubMed ID: 29617698
[TBL] [Abstract][Full Text] [Related]
8.
Orazi G; O'Toole GA
mBio; 2017 Jul; 8(4):. PubMed ID: 28720732
[TBL] [Abstract][Full Text] [Related]
9.
Kiedrowski MR; Gaston JR; Kocak BR; Coburn SL; Lee S; Pilewski JM; Myerburg MM; Bomberger JM
mSphere; 2018 Aug; 3(4):. PubMed ID: 30111629
[No Abstract] [Full Text] [Related]
10. Staphylococcus aureus Impacts Pseudomonas aeruginosa Chronic Respiratory Disease in Murine Models.
Cigana C; Bianconi I; Baldan R; De Simone M; Riva C; Sipione B; Rossi G; Cirillo DM; Bragonzi A
J Infect Dis; 2018 Mar; 217(6):933-942. PubMed ID: 29216403
[TBL] [Abstract][Full Text] [Related]
11.
Yadav MK; Chae SW; Go YY; Im GJ; Song JJ
Front Cell Infect Microbiol; 2017; 7():125. PubMed ID: 28459043
[No Abstract] [Full Text] [Related]
12. Positive signature-tagged mutagenesis in Pseudomonas aeruginosa: tracking patho-adaptive mutations promoting airways chronic infection.
Bianconi I; Milani A; Cigana C; Paroni M; Levesque RC; Bertoni G; Bragonzi A
PLoS Pathog; 2011 Feb; 7(2):e1001270. PubMed ID: 21304889
[TBL] [Abstract][Full Text] [Related]
13. Exogenous Alginate Protects Staphylococcus aureus from Killing by Pseudomonas aeruginosa.
Price CE; Brown DG; Limoli DH; Phelan VV; O'Toole GA
J Bacteriol; 2020 Mar; 202(8):. PubMed ID: 31792010
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms of phagocytosis and host clearance of Pseudomonas aeruginosa.
Lovewell RR; Patankar YR; Berwin B
Am J Physiol Lung Cell Mol Physiol; 2014 Apr; 306(7):L591-603. PubMed ID: 24464809
[TBL] [Abstract][Full Text] [Related]
15. [Infections of the respiratory tract with Pseudomonas aeruginosa in cystic fibrosis].
Winkler U; Wingender J; Jäger KE
Klin Wochenschr; 1985 Jun; 63(11):490-8. PubMed ID: 3925219
[TBL] [Abstract][Full Text] [Related]
16. Emergence and persistence of Pseudomonas aeruginosa in the cystic fibrosis airway.
Fick RB; Sonoda F; Hornick DB
Semin Respir Infect; 1992 Sep; 7(3):168-78. PubMed ID: 1475541
[TBL] [Abstract][Full Text] [Related]
17. Co-infection with Pseudomonas aeruginosa impacts virulence of Staphylococcus aureus and intensifies the severity of infection.
Shoaib A; Lone NA; Yi X
Pak J Pharm Sci; 2020 Sep; 33(5):1933-1937. PubMed ID: 33824098
[TBL] [Abstract][Full Text] [Related]
18. Unveiling the early events of Pseudomonas aeruginosa adaptation in cystic fibrosis airway environment using a long-term in vitro maintenance.
Sousa AM; Monteiro R; Pereira MO
Int J Med Microbiol; 2018 Dec; 308(8):1053-1064. PubMed ID: 30377031
[TBL] [Abstract][Full Text] [Related]
19. Mucoid Pseudomonas aeruginosa growing in a biofilm in vitro are killed by opsonic antibodies to the mucoid exopolysaccharide capsule but not by antibodies produced during chronic lung infection in cystic fibrosis patients.
Meluleni GJ; Grout M; Evans DJ; Pier GB
J Immunol; 1995 Aug; 155(4):2029-38. PubMed ID: 7636254
[TBL] [Abstract][Full Text] [Related]
20. Microenvironmental characteristics and physiology of biofilms in chronic infections of CF patients are strongly affected by the host immune response.
Jensen PØ; Kolpen M; Kragh KN; Kühl M
APMIS; 2017 Apr; 125(4):276-288. PubMed ID: 28407427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
